Enhanced natural killer cell anti-tumor activity with Erastin mediated ferroptosis and potential therapeutic application in neuroblastoma. (EACR 2025) - Jun 29, 2025 - Abstract #P-518; Pres time: Jul 18, 2025; 10:45 AM - 08:00 PM; Location: Poster and Exhibition Hall; Poster Board No EACR25-1823; "Our results suggest that the NK cell's cytotoxic function can be enhanced with Erastin mediated ferroptosis which might be beneficial for NB patients."
Neuroblastoma • Oncology • Pediatrics • Solid Tumor • ATF4 • NKG2D • ULBP1
|
|
V. Anthonydhason 1; E. Islamagic 2; T. Martinsson 2; S. Fransson 2; F. Thoren 2; G. Umapathy 2
|